TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

Funding News - New Uses for Existing Radioligands

Archive folder iconHistorical Data

  • The information on this page is for historical and research purposes only.
  • For the most current NINDS funding announcements, please see the NINDS list of Active Funding Initiatives or Follow Us on Twitter for the latest funding news.

NINDS requests applications for collaborative research to explore new uses for existing radioligands. This request is made together with 3 other NIH components.

The purpose of this funding opportunity is to stimulate research collaborations between two or more laboratories or sites at different institutions to enhance the use of radiopharmaceuticals in positron emission tomography or single photon emission computed tomography (PET/SPECT).  PET/SPECT technology has been extremely useful in evaluating and characterizing brain and other organ systems, in furthering the understanding of disease processes, and in monitoring the effects of therapeutic interventions.  However, one of the biggest limitations of PET/SPECT is the general lack of availability of radiopharmaceutical/radioligand imaging agents.

Letters Of Intent Date:  December 28, 2007.
Application Receipt Date: January 28, 2008.

Potential applicants should contact Dr. Debra Babcock, Program Director, Systems and Cognitive Neuroscience Cluster, NINDS; telephone: 301-496-9964; email: For a more detailed description of this program announcement, visit